Intellectual Property India Publishes Patent Application for 'Dual Inhibitor Kallikrein Antibodies And Uses Thereof' Filed by Triveni Bio, Inc.

MUMBAI, India, Nov. 21 -- Intellectual Property India has published a patent application (202517097423 A) filed by Triveni Bio, Inc., Watertown, U.S.A., on Oct. 9, for 'dual inhibitor kallikrein antibodies and uses thereof.'

Inventor(s) include Dovey, Jennifer, L.; Capili, Allan; Zon, Leonard; Entova, Sonya; Nordyke, Christopher; Calvino, Jenna; Borland, Todd; Tang, Ye; Herrin, Brantley; Lunde, Bradley; and Sharkey, Nathan.

The application for the patent was published on Nov. 21, under issue no. 47/2025.

According to the abstract released by the Intellectual Property India: "Aspects of the application provide dual inhibitor anti-KLK5/KLK7 antibodies and methods of using the same for promoting barrier function and reducing inflammation, and treating conditions such as Netherton syndrome, eosinophilic esophagitis and atopic dermatitis."

The patent application was internationally filed on Mar. 08, 2024, under International application No.PCT/US2024/019231.

Disclaimer: Curated by HT Syndication.